Skip to main content

Table 4 Opinion about the importance, effectiveness and cost-effectiveness of smoking cessation interventions by country (scale responses: 1 = strongly disagree; 7 = strongly agree)

From: Similarities and differences between stakeholders’ opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey

  Netherlands Hungary Germany Spain United Kingdom Total Kruskal–Wallis test
Statements n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) P value
The smoking epidemic is not severe in my country 28 2.00 (1.39) 16 1.44 (0.89) 17 1.82 (1.13) 18 1.50 (0.86) 14 2.50 (1.65) 93 1.85 (1.251) 0.10
Most smoking cessation interventions are effective 28 3.79 (1.52) 16 2.63 (1.31) 17 2.71 (0.85) 18 4.67 (1.75) 14 4.79 (1.42) 93 3.71 (1.639) < 10–3
Most smoking cessation interventions are cost-effective 28 4.11 (1.91) 14 2.64 (1.48) 17 3.18 (1.67) 16 4.75 (1.88) 14 5.71 (1.27) 89 4.07 (1.941) < 10–3
It is important to use smoking cessation interventions because smoking kills a lot of people 28 6.46 (0.79) 16 6.88 (0.50) 17 5.82 (1.51) 18 6.83 (0.51) 14 6.71 (0.47) 93 6.53 (0.916) 0.009
It is important to use smoking cessation interventions because smoking costs a lot for the society 28 6.14 (1.01) 16 6.75 (0.78) 17 5.76 (1.56) 18 6.67 (0.69) 14 6.43 (0.76) 93 6.32 (1.055) 0.032
It is unacceptable that we use smoking cessation interventions without knowing their efficacy 27 5.89 (1.05) 16 6.88 (0.34) 17 5.65 (1.62) 17 5.41 (1.54) 14 5.43 (1.22) 91 5.86 (1.304) 0.003
It is unacceptable that we use smoking cessation interventions without knowing their cost-effectiveness 27 5.04 (1.56) 16 6.00 (1.41) 17 5.12 (1.73) 18 4.50 (1.79) 14 5.07 (1.39) 92 5.12 (1.623) 0.092
  1. SD, Standard deviation